*Department of Pathology, Genetic Pathology Evaluation Centre of the Prostate Research Centre, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, BC
†Institute of Pathology, Charité Hospital, Berlin, Germany
‡Surgical Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY
§Surgical Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
∥Department of Laboratory Medicine and Pathology, University of Alberta and Royal Alexandra Hospital, Edmonton, AB, Canada
Funded by the National Cancer Institute of Canada (no. 017051), the Michael Smith Foundation for Health Research Unit Grant (no. INRUA006045) to C. Blake Gilks, and by an unrestricted educational grant from Sanofi-Aventis. Supported by the Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency. Martin Köbel received fellowship support from Eli Lilly Canada.
Correspondence: C. Blake Gilks, MD, MD, FRCPC, Department of Pathology, Room 1207, First floor JPPN, Vancouver General Hospital, 855 West 12th Avenue, Vancouver, BC, Canada, V5Z 1M9 (e-mail: [email protected]).